Chinese vaccine granted patent for authorisation

China is now the newest country in the world following the footsteps of Russia to register its novel vaccine for Covid-19 produced by CanSino biopharmaceutical firm. Chinese authorities granted the patent after studies proved that the vaccine prototype concurred with creative and intellectual property bases set by Beijing officials. The Chinese vaccine titled Ad5-nCOV was…

UK signs for 90 million virus vaccine doses

    The UK government has signed a deal for a further 90 million coronavirus vaccine with the Belgian Pharmaceutical company Janssen and the US biotech company Novavax.  This brings the tally of UK orders for six experimental vaccines to 340 million doses including 100 million doses of  Adenovirus vaccines by Oxford University/ AstraZeneca, 30…

Covid-19 : Prevention is much easier than cure

Researches behind a global study into Hydroxychloroquine led by Oxford University have against dismissing the drug prematurely, saying it could still save lives. The study, known as Copcov, aims to enroll 40, 000 healthcare workers from across the world to determine whether the drug is effective at fighting Covid-19. Dr. Will Schilling the trail’s lead…

Fourth covid-19 vaccine deal signed for 60m doses

GSK-Sanofi vaccine A fourth coronavirus vaccine deal has been signed by the UK government, securing up to 60 million doses of an experimental treatment being developed by  GSK and Sanofi. The government has already signed up for 100 million doses of the Oxford University vaccine being developed by AstraZeneca and another 90 million doses of…

Dexamethasone steroid – a major breakthrough in treating Covid-19

Dexamethasone, a cheap genetic steroid has proven to become the first life-saving drug treatment in the Covid-19 pandemic. The low-dose steroid treatment Dexamethasone is part of the world’s biggest trial testing existing treatments to see if they also work for coronavirus, and found it cut the risk of death by a  third for patients on…

Novartis joins the accelerated COVID-19 (ACTIV) initiative

Novartis commits to donating up to 130million doses of Hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and a related drug Chloroquine are currently under evaluation in clinical trials for the treatment of COVID-19. Novartis COVID-19 Response Fund of  USD 20 million, helped to build drug discovery and development collaborations and essential medicines price…

Testing started for coronavirus vaccine

In February Moderna Therapeutics, Cambridge-based (near Boston) biotech group, smashed a record for the fastest time between identifying a virus ( Covid-19) and creating a vaccine ready to test on humans in 42 days. Juan Andres, a former Novartis executive to help it ramp up manufacturing of its experimental drugs and vaccine at the new…

Thermo Fishers acquires Dutch diagnostics group Qiagen for $11.5bn

The  US Scientific equipment maker, Thermo Fisher with a market capitalisation of $122bn, has agreed to buy Dutch diagnostics group Qlagen for $11.5bn in a move to extend their disease testing capabilities as the world is gripped by the Coronavirus outbreak. Qiagen, a provider for sample and Assay technologies for molecular diagnostics, applied testing, academic…